WHO’s New TB Test: Faster, Cheaper, Better

A gloved hand holding a test tube labeled 'Legionella' among other samples

Tongue swabs could soon diagnose tuberculosis faster than ever, transforming how we catch this ancient killer before it spreads silently through communities.

Story Highlights

WHO endorses near-point-of-care molecular tests for initial TB detection at peripheral clinics, decentralizing diagnosis for the first time.
Tongue swabs enable easy sample collection from adults and adolescents unable to produce sputum, targeting vulnerable patients.
Sputum pooling cuts costs and boosts efficiency in resource-limited settings, addressing global diagnostic gaps.
These updates align with the End TB Strategy, aiming to reduce delays and save millions of lives annually.
Full guidelines, toolkits, and webinars roll out in 2026 to support national programs worldwide.

WHO Announces Breakthrough TB Diagnostic Recommendations

On March 9, 2026, WHO released updated guidelines recommending near-point-of-care (NPOC) molecular tests, known as NPOC-NAATs, for detecting TB without rifampicin resistance at peripheral health centers. These tests deliver results within hours, bypassing central labs. Dr. Tereza Kasaeva, WHO’s Director for HIV/TB/Hepatitis/STIs, called this a major advance in accessibility. Countries now prepare to integrate these tools into frontline care.

Tongue Swabs Revolutionize Sample Collection for Non-Sputum Producers

Tongue swabs provide a simple alternative for adults and adolescents who cannot produce sputum, a common barrier in TB diagnosis. Patients unable to cough up samples often face delays or missed cases. This method, backed by new evidence, allows immediate collection in clinics. Vulnerable groups like those with HIV or weakened respiratory function gain quicker access to testing and treatment.

WHO recommends new diagnostic tools to help end TB

Read our story :https://t.co/HksWFwUZSE

Photo: Reuters

Follow us:⁠
FB: https://t.co/8zl049meaJ⁠
YouTube: OurToday⁠
X: Our_Today_News⁠
IG: @our.today⁠
TikTok: @ourtodaynews#OTNews #JAM pic.twitter.com/9tisr90ERo

— OUR TODAY (@Our_Today_News) March 24, 2026

Sputum Pooling Enhances Efficiency in High-Burden Areas

Sputum pooling combines samples from multiple patients for initial testing, reducing costs and workload in resource-constrained settings. Liverpool School of Tropical Medicine’s Start4All project proved its feasibility, showing high accuracy while cutting expenses. National TB programs in low-income countries stand to benefit most, scaling up screening without overwhelming labs. This strategy promises broader reach where TB hits hardest.

Historical Evolution of TB Diagnostics Drives These Changes

TB testing progressed from basic sputum microscopy to advanced molecular methods like LC-aNAATs. WHO’s 2025 consolidated guidelines unified detection of infection, disease, and resistance. The End TB Strategy, adopted in 2014 and reaffirmed at the UN, demands rapid, universal access amid persistent gaps from lab dependency and high costs. New evidence post-2025 triggered this second edition.

Stakeholders Collaborate for Global Implementation

WHO leads with GRADE-evaluated evidence, partnering with researchers like LSTM for data on swabs and pooling. National programs implement via upcoming toolkits and webinars. Guideline Development Groups review ongoing innovations, such as AI cough analyzers. Dr. Kasaeva urges rapid rollout, emphasizing vulnerable populations including children, PLHIV, and those in high-burden regions.

Impacts Promise Progress Toward Ending TB

Short-term gains include faster peripheral testing and cost savings, easing access for sputum-challenged patients. Long-term, reduced delays cut incidence and mortality, advancing End TB targets. Economically, pooling lowers unit costs; socially, decentralization aids the poor; politically, it fulfills UN pledges. Industry shifts favor molecular tech and AI, informing future evaluations.